While everyone is discussing are we in an AI bubble or not, Harvard is teaching how to invest in these irrational times.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Ricursive joins Recursive and Unconventional AI in raising massive funds at multi-billion valuations out of the gate.

Sundance: Telling three parallel stories at various points in time, Stanton's film spans 47,000 years in search of a single believable moment.

One way leads to a future in which AI-driven breakthroughs remain the exclusive domain of pharmaceutical giants with billion-dollar budgets. The other, to a landscape where breakthroughs regularly ...

Equity-Insider.com News Commentary ? The global AI medical imaging market exploded to a staggering $2.57 trillion in 2026 as the entire healthcare ecosystem ditched trial-and-error medicine for ...

Imagine the final stages of an audit engagement are due in the next few days. During this concluding phase, you anxiously await forthcoming review points from the engagement quality (EQ) reviewer. The ...

Cellino, a regenerative medicine company developing autonomous manufacturing systems for personalized cells, today announced the expansion of co-founder Dr. Marinna Madrid's role to Chief Product and ...

Python.Org is the official source for documentation and beginner guides. Codecademy and Coursera offer interactive courses for learning Python basics. Think Python provides a free e-book for a ...

Explore the competition between Recursive and Ricursive startups in Silicon Valley aiming to build AI systems that ...

This past December, Perseverance successfully completed a route through a section of the Jezero crater plotted by Anthropic's ...